Yüklüyor......
The development of proteinase-activated receptor-2 modulators and the challenges involved
Protease-activated receptor-2 (PAR2) has been extensively studied since its discovery in the mid-1990. Despite the advances in understanding PAR2 pharmacology, it has taken almost 25 years for the first inhibitor to reach clinical trials, and so far, no PAR2 antagonist has been approved for human us...
Kaydedildi:
| Yayımlandı: | Biochem Soc Trans |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Portland Press Ltd.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752072/ https://ncbi.nlm.nih.gov/pubmed/33242065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BST20200191 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|